Pinned Tweet
Sean is taking a break from Twitter. If he ever decides to get back to it, it will be from this account.
Purpose. Immix BioPharma
seansenn.com/2020/10/01/purp…
@ImmixBio @commonspirit #Biotech4Life #CancerCure #BiotechEntrepreneur #LifeSciences @SoCalBio
Recent short interview on a company focused on dna synthesis (and why that’s different than CRISPR gene editing) #Biotech4Life #molecularbionxtgeneration
google.com/amp/s/www.forbes.…
So far so good on the Dignity Health and CHI merger. Will create the largest nonprofit hospital system. modernhealthcare.com/article…
Sean Senn retweeted
Immix and CEO Ilya Rachman will be presenting our latest results at the 20th Annual SoCalBio Conference this Friday! @SoCalBio #Biotech4Life socalbioinvest.com/register/
Immix and CEO Ilya Rachman will be presenting our latest results at the 20th Annual SoCalBio Conference this Friday! @SoCalBio #Biotech4Life socalbioinvest.com/register/
Surprised to see my name in the article. Sorry to learn Archer Norris is closing up shop. law.com/therecorder/2018/08/…
Just out. Some really amazing new results by Immix in treatment of lymphoma. immixbio.com/2018/08/06/immi…
Some tough news coming out of Europe on Crispr related biotech and future of GMO crops google.com/amp/s/amp.theguar…
Latest results of SuFEx research from TSRI. Results show clearly that SuFEx can successfully modify existing big pharma drugs to significantly improve drug potency. scripps.edu/news/press/2018/…
I’m in Phoenix AZ this week for the annual AUTM meeting. Wasn’t sure until the last minute if I was going to actually be able to attend this year, but I made it! Whew! Been really great to see some old friends and meeting some new. @AUTM #techtransfer4life
Thanks @ArcherNorris, and thanks Immix! Exciting stuff! xitter.cf/ArcherNorris/status/96…
Archer Norris client Immix Biopharma, Inc. (co-founded by AN partner @SeanSenn1) has been approved to begin phase 1/2a study of flagship candidate Imx-110, a combination therapy designed to inhibit cancer resistance and evolvability bit.ly/2Bu3o0k
Big fan of LA biotech entrepreneur Patrick Soon-Shiong. But not sure what’s behind his purchase of LA Times and SD Union Tribune. Hopefully will bring more science awareness into our public conversations. #BiotechWillSaveTheWorld google.com/amp/www.latimes.c…
Biopharma at its best. Also a great interview with Mammen on Human Proof of Concept podcast, which is also a podcast series on VC Biotech worth checking out. forbes.com/sites/davidshaywi…
Trump's pick of Iancu for new head of US patent office is a sign of trouble for biotech start ups. On the other hand, given Trump's past history on nominations, at least this one knows what the patent office is. law360.com/ip/articles/10075…
Ilya Rachman, co-founder of Immix Biopharma, accepting his patent award and a hamburger at the Counter in Miracle Mike today. #MyLeadCmpdCrushedIt #biotech4life
